VIC Team

VIC Team

Recent Posts

Cellia Science Awarded $300K+ NIH SBIR Phase I Grant to Develop Point-of-Care Diagnostic for Spontaneous Bacterial Peritonitis

Cellia Science a biotechnology company advancing rapid, cell-based diagnostic technologies, announced today that it has been awarded a $306,872 Small Business Innovation Research (SBIR) Phase I grant from the National...

Enhance Diagnostics Awarded $307K NIH SBIR Grant to Develop Simple Breath Test for Monitoring Blood Ammonia in UCD Patients

Enhance Diagnostics, announced today that it has been awarded a $307,000 Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Child Health and Human Development (NICHD), part of the...

VIC Tech Expands Strategic Advisory Board with Addition of MedTech Leader Dr. Jeff White

VIC Tech, a venture studio building life science companies from university and federal lab innovations, announced today the appointment of Dr. Jeff White to its Strategic Advisory Board (SAB). A seasoned life science...

Solaris Vaccines Expands Expertise with Appointment of Dr. Taru Dutt as Director of Bacterial Countermeasures

Solaris Vaccines, a biotechnology company pioneering a novel approach to vaccine development, announced the appointment of Taru Dutt, PhD, as Director of Bacterial Countermeasures. This strategic addition strengthens...

Bridging Science and Industry: A Conversation with Alberto Schena of Knowledge Transfer UNIL CHUV

You are part of Knowledge Transfer UNIL CHUV. Could you describe these organizations for readers who are familiar with them? The Lausanne University Hospital (CHUV) is one of Switzerland’s five university hospitals and...

Solaris Vaccines Strengthens Scientific Leadership with Appointment of Dr. Jonathan O. Rayner

Solaris Vaccines, a biotechnology company pioneering a novel approach to vaccine development, announced the addition of an accomplished scientist to its leadership team. Jonathan O. Rayner, PhD, joins as Chief...

VIC Tech Announces New Class of Fellows

The VIC Tech investment model is unique, sourcing promising life science innovations directly from universities nationwide. It provides funding to launch startup companies and advance these technologies, ultimately...

VIC Tech 2025 Mid-Year Update

VIC Tech achieved key milestones in H1 2025, including portfolio advancements, strategic partnerships, and talent development. We remain focused on FDA submissions, clinical trials, and scaling initiatives to drive...

VIC Tech Expands Strategic Advisory Board with Addition of MedTech Innovator and Gastroenterology Expert Virender “VK” Sharma, MD

VIC Tech, a venture studio building life science companies from university and federal lab innovations, announced today the appointment of Virender “VK” Sharma, MD, to its Strategic Advisory Board (SAB). A recognized...

Women Shaping Life Sciences: Laura Lyons on Purpose, Perseverance, and Patient-Centered Innovation

In an industry where advanced degrees and technical titles often take center stage, Laura Lyons brings something just as powerful to the table; lived experience, heart, and a relentless drive to make life better for...

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Women Shaping Life Sciences: Laura Lyons on Purpose, Perseverance, and Patient-Centered Innovation
White Paper
Fostering Life Science Innovation: Part 2 – Inventing with the End in Mind
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Fostering Life Science Innovation: Part 1 – An Ecosystem Roadmap
News
SFC Fluidics Collaborating with Duracell to Power Innovative Diabetes Devices
Interview
VIC Fellows Spotlight: Nicole Shirkey-Son, PhD
From The Corner Office
From the Corner Office with Enhance Diagnostics